NFE2L1 Human (S)-nicotine increases splicing EXP 6480464 Nicotine results in increased splicing of NFE2L1 mRNA alternative form CTD PMID:23825647 NFE2L1 Human 1,2-dimethylhydrazine increases expression ISO Nfe2l1 (Mus musculus) 6480464 1 and 2-Dimethylhydrazine results in increased expression of NFE2L1 mRNA CTD PMID:22206623 NFE2L1 Human 17alpha-ethynylestradiol increases expression ISO Nfe2l1 (Mus musculus) 6480464 Ethinyl Estradiol results in increased expression of NFE2L1 mRNA CTD PMID:17942748 NFE2L1 Human 17alpha-ethynylestradiol multiple interactions ISO Nfe2l1 (Mus musculus) 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of NFE2L1 mRNA CTD PMID:17942748 NFE2L1 Human 17beta-estradiol increases expression EXP 6480464 Estradiol results in increased expression of NFE2L1 mRNA and Estradiol results in increased expression of NFE2L1 protein CTD PMID:25130429 and PMID:28960787 NFE2L1 Human 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO Nfe2l1 (Mus musculus) 6480464 Tetrachlorodibenzodioxin affects the expression of NFE2L1 mRNA CTD PMID:21570461 and PMID:24058054 NFE2L1 Human 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO Nfe2l1 (Rattus norvegicus) 6480464 Tetrachlorodibenzodioxin affects the expression of NFE2L1 mRNA CTD PMID:34747641 NFE2L1 Human 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO Nfe2l1 (Mus musculus) 6480464 Tetrachlorodibenzodioxin results in decreased expression of NFE2L1 mRNA CTD PMID:28213091 NFE2L1 Human 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO Nfe2l1 (Mus musculus) 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of NFE2L1 mRNA CTD PMID:17942748 NFE2L1 Human 2-hydroxypropanoic acid increases expression EXP 6480464 Lactic Acid results in increased expression of NFE2L1 mRNA CTD PMID:30851411 NFE2L1 Human 2-tert-butylhydroquinone increases expression EXP 6480464 2-tert-butylhydroquinone results in increased expression of NFE2L1 protein CTD PMID:33838154 NFE2L1 Human 3,4-methylenedioxymethamphetamine increases expression ISO Nfe2l1 (Mus musculus) 6480464 N-Methyl-3 and 4-methylenedioxyamphetamine results in increased expression of NFE2L1 mRNA CTD PMID:20188158 NFE2L1 Human 3,4-methylenedioxymethamphetamine decreases methylation ISO Nfe2l1 (Mus musculus) 6480464 N-Methyl-3 and 4-methylenedioxyamphetamine results in decreased methylation of NFE2L1 promoter CTD PMID:26251327 NFE2L1 Human 3,4-methylenedioxymethamphetamine decreases expression ISO Nfe2l1 (Mus musculus) 6480464 N-Methyl-3 and 4-methylenedioxyamphetamine results in decreased expression of NFE2L1 mRNA CTD PMID:26251327 NFE2L1 Human 3-isobutyl-1-methyl-7H-xanthine multiple interactions EXP 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of NFE2L1 mRNA CTD PMID:28628672 NFE2L1 Human 4,4'-sulfonyldiphenol affects methylation ISO Nfe2l1 (Mus musculus) 6480464 bisphenol S affects the methylation of NFE2L1 gene CTD PMID:31683443 NFE2L1 Human 4,4'-sulfonyldiphenol multiple interactions ISO Nfe2l1 (Rattus norvegicus) 6480464 [bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of NFE2L1 mRNA CTD PMID:36041667 NFE2L1 Human 4-hydroxynon-2-enal decreases expression EXP 6480464 4-hydroxy-2-nonenal results in decreased expression of NFE2L1 mRNA CTD PMID:12419474 NFE2L1 Human 4-hydroxyphenyl retinamide decreases expression ISO Nfe2l1 (Mus musculus) 6480464 Fenretinide results in decreased expression of NFE2L1 mRNA CTD PMID:28973697 NFE2L1 Human 5-aza-2'-deoxycytidine affects methylation EXP 6480464 Decitabine affects the methylation of NFE2L1 gene CTD PMID:17630775 NFE2L1 Human acrolein multiple interactions EXP 6480464 3 more ... CTD PMID:20938484 NFE2L1 Human acrolein decreases expression EXP 6480464 Acrolein results in decreased expression of NFE2L1 mRNA and Acrolein results in decreased expression of NFE2L1 protein CTD PMID:20938484 NFE2L1 Human aldehydo-D-glucose increases expression EXP 6480464 Glucose results in increased expression of NFE2L1 mRNA and Glucose results in increased expression of NFE2L1 protein CTD PMID:33838154 NFE2L1 Human aldehydo-D-glucose multiple interactions EXP 6480464 benzyloxycarbonylleucyl-leucyl-leucine aldehyde promotes the reaction [Glucose results in increased expression of NFE2L1 protein] and Glucose promotes the reaction [benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in increased expression of NFE2L1 protein] CTD PMID:33838154 NFE2L1 Human antimycin A increases expression EXP 6480464 Antimycin A results in increased expression of NFE2L1 mRNA CTD PMID:33512557 NFE2L1 Human aristolochic acid A decreases expression EXP 6480464 aristolochic acid I results in decreased expression of NFE2L1 mRNA CTD PMID:33212167 NFE2L1 Human Aroclor 1254 decreases expression ISO Nfe2l1 (Mus musculus) 6480464 Chlorodiphenyl (54% Chlorine) results in decreased expression of NFE2L1 mRNA CTD PMID:23650126 NFE2L1 Human arsane increases expression EXP 6480464 Arsenic results in increased expression of NFE2L1 CTD PMID:21235219 NFE2L1 Human arsane multiple interactions EXP 6480464 [NFE2L1 protein alternative form co-treated with [sodium arsenite results in increased abundance of Arsenic]] results in increased expression of NFE2L2 mRNA more ... CTD PMID:32188015 NFE2L1 Human arsenic atom increases expression EXP 6480464 Arsenic results in increased expression of NFE2L1 CTD PMID:21235219 NFE2L1 Human arsenic atom multiple interactions EXP 6480464 [NFE2L1 protein alternative form co-treated with [sodium arsenite results in increased abundance of Arsenic]] results in increased expression of NFE2L2 mRNA more ... CTD PMID:32188015 NFE2L1 Human arsenite(3-) decreases expression EXP 6480464 arsenite results in decreased expression of NFE2L1 mRNA CTD PMID:22476201 NFE2L1 Human arsenite(3-) decreases methylation ISO Nfe2l1 (Mus musculus) 6480464 NFE2L1 protein alternative form results in decreased methylation of arsenite CTD PMID:28549828 NFE2L1 Human arsenite(3-) multiple interactions ISO Nfe2l1 (Mus musculus) 6480464 [NFE2L1 protein alternative form results in decreased methylation of arsenite] which results in decreased abundance of monomethylarsonic acid more ... CTD PMID:28549828 and PMID:32980394 NFE2L1 Human arsenite(3-) increases expression ISO Nfe2l1 (Mus musculus) 6480464 arsenite results in increased expression of NFE2L1 mRNA and arsenite results in increased expression of NFE2L1 protein alternative form CTD PMID:32980394 NFE2L1 Human arsenite(3-) affects export ISO Nfe2l1 (Mus musculus) 6480464 NFE2L1 alternative form affects the export of arsenite CTD PMID:32980394 NFE2L1 Human arsenite(3-) affects response to substance ISO Nfe2l1 (Mus musculus) 6480464 NFE2L1 alternative form affects the susceptibility to arsenite CTD PMID:32980394 NFE2L1 Human arsenite(3-) increases expression EXP 6480464 arsenite results in increased expression of NFE2L1 protein CTD PMID:22476201 and PMID:35124418 NFE2L1 Human arsenite(3-) multiple interactions EXP 6480464 KEAP1 protein affects the reaction [arsenite results in decreased expression of NFE2L1 mRNA] more ... CTD PMID:22476201 NFE2L1 Human arsenite(3-) affects response to substance EXP 6480464 NFE2L1 protein affects the susceptibility to arsenite CTD PMID:22476201 NFE2L1 Human arsenous acid multiple interactions EXP 6480464 Arsenic Trioxide results in increased expression of and results in increased activity of NFE2L1 protein CTD PMID:16487037 NFE2L1 Human atorvastatin calcium increases expression ISO Nfe2l1 (Mus musculus) 6480464 Atorvastatin results in increased expression of NFE2L1 mRNA CTD PMID:30511338 NFE2L1 Human benzo[a]pyrene increases expression ISO Nfe2l1 (Mus musculus) 6480464 Benzo(a)pyrene results in increased expression of NFE2L1 mRNA CTD PMID:22228805 NFE2L1 Human benzo[a]pyrene decreases methylation EXP 6480464 Benzo(a)pyrene results in decreased methylation of NFE2L1 promoter CTD PMID:27901495 NFE2L1 Human bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of NFE2L1 mRNA CTD PMID:23360430 and PMID:29275510 NFE2L1 Human bisphenol A multiple interactions ISO Nfe2l1 (Rattus norvegicus) 6480464 [bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of NFE2L1 mRNA CTD PMID:36041667 NFE2L1 Human bisphenol A decreases expression ISO Nfe2l1 (Rattus norvegicus) 6480464 bisphenol A results in decreased expression of NFE2L1 mRNA CTD PMID:34947998 and PMID:35887390 NFE2L1 Human bisphenol A affects methylation ISO Nfe2l1 (Mus musculus) 6480464 bisphenol A affects the methylation of NFE2L1 promoter CTD PMID:27334623 NFE2L1 Human bisphenol A multiple interactions EXP 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of NFE2L1 mRNA CTD PMID:28628672 NFE2L1 Human bisphenol A increases expression ISO Nfe2l1 (Rattus norvegicus) 6480464 bisphenol A results in increased expression of NFE2L1 mRNA CTD PMID:25181051 NFE2L1 Human bisphenol F multiple interactions ISO Nfe2l1 (Rattus norvegicus) 6480464 [bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of NFE2L1 mRNA CTD PMID:36041667 NFE2L1 Human brefeldin A multiple interactions EXP 6480464 Brefeldin A affects the reaction [sodium arsenite affects the localization of NFE2L1 protein] CTD PMID:20805060 NFE2L1 Human cannabidiol increases expression ISO Nfe2l1 (Mus musculus) 6480464 Cannabidiol results in increased expression of NFE2L1 mRNA CTD PMID:21542829 NFE2L1 Human carbamazepine affects expression EXP 6480464 Carbamazepine affects the expression of NFE2L1 mRNA CTD PMID:25979313 NFE2L1 Human choline multiple interactions ISO Nfe2l1 (Mus musculus) 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of NFE2L1 gene CTD PMID:20938992 NFE2L1 Human cisplatin multiple interactions EXP 6480464 Cisplatin promotes the reaction [Piroxicam results in decreased expression of NFE2L1 mRNA] CTD PMID:21858171 NFE2L1 Human clofibrate decreases expression ISO Nfe2l1 (Mus musculus) 6480464 Clofibrate results in decreased expression of NFE2L1 mRNA CTD PMID:17585979 NFE2L1 Human cobalt dichloride multiple interactions ISO Nfe2l1 (Rattus norvegicus) 6480464 [cobaltous chloride co-treated with Oxygen deficiency] results in increased expression of NFE2L1 protein CTD PMID:19278353 NFE2L1 Human cobalt dichloride increases expression ISO Nfe2l1 (Rattus norvegicus) 6480464 cobaltous chloride results in increased expression of NFE2L1 protein CTD PMID:19278353 NFE2L1 Human cocaine increases expression EXP 6480464 Cocaine results in increased expression of NFE2L1 mRNA CTD PMID:18000554 NFE2L1 Human curcumin increases expression EXP 6480464 Curcumin results in increased expression of NFE2L1 protein CTD PMID:23710286 NFE2L1 Human cyclosporin A increases expression EXP 6480464 Cyclosporine results in increased expression of NFE2L1 mRNA CTD PMID:20106945 and PMID:27989131 NFE2L1 Human D-glucose multiple interactions EXP 6480464 benzyloxycarbonylleucyl-leucyl-leucine aldehyde promotes the reaction [Glucose results in increased expression of NFE2L1 protein] and Glucose promotes the reaction [benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in increased expression of NFE2L1 protein] CTD PMID:33838154 NFE2L1 Human D-glucose increases expression EXP 6480464 Glucose results in increased expression of NFE2L1 mRNA and Glucose results in increased expression of NFE2L1 protein CTD PMID:33838154 NFE2L1 Human decabromodiphenyl ether multiple interactions ISO Nfe2l1 (Rattus norvegicus) 6480464 [Flame Retardants co-treated with pentabromodiphenyl ether co-treated with decabromobiphenyl ether co-treated with hexabromocyclododecane] results in increased expression of NFE2L1 mRNA CTD PMID:32207525 NFE2L1 Human deguelin increases expression EXP 6480464 deguelin results in increased expression of NFE2L1 mRNA CTD PMID:33512557 NFE2L1 Human dexamethasone increases expression ISO Nfe2l1 (Rattus norvegicus) 6480464 Dexamethasone results in increased expression of NFE2L1 mRNA CTD PMID:20032058 NFE2L1 Human dexamethasone multiple interactions EXP 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of NFE2L1 mRNA CTD PMID:28628672 NFE2L1 Human dexamethasone multiple interactions ISO Nfe2l1 (Rattus norvegicus) 6480464 Testosterone inhibits the reaction [Dexamethasone results in increased expression of NFE2L1 mRNA] CTD PMID:20032058 NFE2L1 Human diarsenic trioxide multiple interactions EXP 6480464 Arsenic Trioxide results in increased expression of and results in increased activity of NFE2L1 protein CTD PMID:16487037 NFE2L1 Human dioxygen multiple interactions ISO Nfe2l1 (Rattus norvegicus) 6480464 [cobaltous chloride co-treated with Oxygen deficiency] results in increased expression of NFE2L1 protein CTD PMID:19278353 NFE2L1 Human dioxygen increases expression ISO Nfe2l1 (Rattus norvegicus) 6480464 Oxygen deficiency results in increased expression of NFE2L1 protein CTD PMID:19278353 NFE2L1 Human disodium selenite increases expression EXP 6480464 Sodium Selenite results in increased expression of NFE2L1 mRNA CTD PMID:24383545 NFE2L1 Human dorsomorphin decreases expression EXP 6480464 dorsomorphin results in decreased expression of NFE2L1 protein CTD PMID:33838154 NFE2L1 Human doxorubicin increases expression EXP 6480464 Doxorubicin results in increased expression of NFE2L1 protein CTD PMID:26781513 NFE2L1 Human doxorubicin decreases expression EXP 6480464 Doxorubicin results in decreased expression of NFE2L1 mRNA and Doxorubicin results in decreased expression of NFE2L1 protein CTD PMID:26781513 and PMID:29803840 NFE2L1 Human doxorubicin multiple interactions EXP 6480464 PPARGC1A affects the reaction [Doxorubicin results in decreased expression of NFE2L1 protein] and PPARGC1A affects the reaction [Doxorubicin results in increased expression of NFE2L1 protein] CTD PMID:26781513 NFE2L1 Human endosulfan decreases expression ISO Nfe2l1 (Rattus norvegicus) 6480464 Endosulfan results in decreased expression of NFE2L1 mRNA CTD PMID:29391264 NFE2L1 Human epoxomicin multiple interactions ISO Nfe2l1 (Mus musculus) 6480464 NFE2L1 alternative form affects the reaction [epoxomicin results in increased expression of NFE2L1 protein alternative form] CTD PMID:32980394 NFE2L1 Human epoxomicin multiple interactions EXP 6480464 epoxomicin results in increased expression of and affects the localization of NFE2L1 protein more ... CTD PMID:27345029 NFE2L1 Human epoxomicin increases expression ISO Nfe2l1 (Mus musculus) 6480464 epoxomicin results in increased expression of NFE2L1 protein alternative form CTD PMID:32980394 NFE2L1 Human ethanol affects splicing ISO Nfe2l1 (Mus musculus) 6480464 Ethanol affects the splicing of NFE2L1 mRNA CTD PMID:30319688 NFE2L1 Human fenthion decreases expression ISO Nfe2l1 (Mus musculus) 6480464 Fenthion results in decreased expression of NFE2L1 mRNA CTD PMID:34813904 NFE2L1 Human finasteride increases expression ISO Nfe2l1 (Rattus norvegicus) 6480464 Finasteride results in increased expression of NFE2L1 mRNA CTD PMID:24136188 NFE2L1 Human folic acid multiple interactions ISO Nfe2l1 (Mus musculus) 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of NFE2L1 gene CTD PMID:20938992 NFE2L1 Human gentamycin decreases expression ISO Nfe2l1 (Rattus norvegicus) 6480464 Gentamicins results in decreased expression of NFE2L1 mRNA CTD PMID:22061828 NFE2L1 Human geraniol increases expression EXP 6480464 geraniol results in increased expression of NFE2L1 mRNA CTD PMID:27683099 NFE2L1 Human glafenine decreases expression ISO Nfe2l1 (Rattus norvegicus) 6480464 Glafenine results in decreased expression of NFE2L1 mRNA CTD PMID:24136188 NFE2L1 Human glucose increases expression EXP 6480464 Glucose results in increased expression of NFE2L1 mRNA and Glucose results in increased expression of NFE2L1 protein CTD PMID:33838154 NFE2L1 Human glucose multiple interactions EXP 6480464 benzyloxycarbonylleucyl-leucyl-leucine aldehyde promotes the reaction [Glucose results in increased expression of NFE2L1 protein] and Glucose promotes the reaction [benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in increased expression of NFE2L1 protein] CTD PMID:33838154 NFE2L1 Human hydrogen peroxide decreases expression EXP 6480464 Hydrogen Peroxide results in decreased expression of NFE2L1 mRNA CTD PMID:12419474 NFE2L1 Human hydroxytyrosol multiple interactions EXP 6480464 3 more ... CTD PMID:20938484 NFE2L1 Human icariin increases expression ISO Nfe2l1 (Mus musculus) 6480464 icariin results in increased expression of NFE2L1 mRNA and icariin results in increased expression of NFE2L1 protein CTD PMID:17883938 NFE2L1 Human indometacin multiple interactions EXP 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of NFE2L1 mRNA CTD PMID:28628672 NFE2L1 Human L-ascorbic acid increases expression EXP 6480464 Ascorbic Acid results in increased expression of NFE2L1 mRNA and Ascorbic Acid results in increased expression of NFE2L1 protein CTD PMID:25130429 NFE2L1 Human L-ascorbic acid 2-phosphate multiple interactions ISO Nfe2l1 (Mus musculus) 6480464 [ascorbate-2-phosphate co-treated with GULO protein] affects the expression of and affects the localization of NFE2L1 protein and NFE2L1 protein affects the reaction [ascorbate-2-phosphate results in increased expression of SP7 mRNA] CTD PMID:17510056 NFE2L1 Human L-methionine multiple interactions ISO Nfe2l1 (Mus musculus) 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of NFE2L1 gene CTD PMID:20938992 NFE2L1 Human metformin increases degradation EXP 6480464 Metformin results in increased degradation of NFE2L1 protein CTD PMID:33838154 NFE2L1 Human metformin decreases expression EXP 6480464 Metformin results in decreased expression of NFE2L1 mRNA and Metformin results in decreased expression of NFE2L1 protein CTD PMID:33838154 NFE2L1 Human metformin multiple interactions EXP 6480464 Metformin inhibits the reaction [benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in increased expression of NFE2L1 protein] CTD PMID:33838154 NFE2L1 Human methidathion decreases expression ISO Nfe2l1 (Mus musculus) 6480464 methidathion results in decreased expression of NFE2L1 mRNA CTD PMID:34813904 NFE2L1 Human methotrexate affects response to substance EXP 6480464 NFE2L1 protein affects the susceptibility to Methotrexate CTD PMID:16217747 NFE2L1 Human methylarsonic acid multiple interactions ISO Nfe2l1 (Mus musculus) 6480464 [NFE2L1 protein alternative form results in decreased methylation of arsenite] which results in decreased abundance of monomethylarsonic acid CTD PMID:28549828 NFE2L1 Human N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal decreases degradation ISO Nfe2l1 (Mus musculus) 6480464 benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in decreased degradation of NFE2L1 protein alternative form CTD PMID:28549828 NFE2L1 Human N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal multiple interactions EXP 6480464 benzyloxycarbonylleucyl-leucyl-leucine aldehyde promotes the reaction [Glucose results in increased expression of NFE2L1 protein] more ... CTD PMID:33838154 NFE2L1 Human N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal increases expression EXP 6480464 benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in increased expression of NFE2L1 protein CTD PMID:33838154 NFE2L1 Human nicotine increases splicing EXP 6480464 Nicotine results in increased splicing of NFE2L1 mRNA alternative form CTD PMID:23825647 NFE2L1 Human p-toluidine increases expression ISO Nfe2l1 (Rattus norvegicus) 6480464 4-toluidine results in increased expression of NFE2L1 mRNA CTD PMID:27638505 NFE2L1 Human paracetamol increases expression EXP 6480464 Acetaminophen results in increased expression of NFE2L1 mRNA CTD PMID:29067470 NFE2L1 Human patulin increases expression ISO Nfe2l1 (Mus musculus) 6480464 Patulin results in increased expression of NFE2L1 protein CTD PMID:35367319 NFE2L1 Human patulin multiple interactions ISO Nfe2l1 (Mus musculus) 6480464 NFE2L1 protein affects the reaction [Patulin results in increased expression of PSMA2 mRNA] more ... CTD PMID:35367319 NFE2L1 Human patulin increases expression EXP 6480464 Patulin results in increased expression of NFE2L1 protein CTD PMID:35367319 NFE2L1 Human patulin affects response to substance ISO Nfe2l1 (Mus musculus) 6480464 NFE2L1 protein affects the susceptibility to Patulin CTD PMID:35367319 NFE2L1 Human patulin affects response to substance EXP 6480464 NFE2L1 protein affects the susceptibility to Patulin CTD PMID:35367319 NFE2L1 Human perfluorooctanoic acid increases expression ISO Nfe2l1 (Rattus norvegicus) 6480464 perfluorooctanoic acid results in increased expression of NFE2L1 mRNA CTD PMID:19616056 NFE2L1 Human pirinixic acid increases expression ISO Nfe2l1 (Mus musculus) 6480464 pirinixic acid results in increased expression of NFE2L1 mRNA CTD PMID:18301758 more ... NFE2L1 Human piroxicam multiple interactions EXP 6480464 Cisplatin promotes the reaction [Piroxicam results in decreased expression of NFE2L1 mRNA] CTD PMID:21858171 NFE2L1 Human piroxicam decreases expression EXP 6480464 Piroxicam results in decreased expression of NFE2L1 mRNA CTD PMID:21858171 NFE2L1 Human rac-lactic acid increases expression EXP 6480464 Lactic Acid results in increased expression of NFE2L1 mRNA CTD PMID:30851411 NFE2L1 Human raloxifene increases expression EXP 6480464 Raloxifene Hydrochloride results in increased expression of NFE2L1 mRNA CTD PMID:16497877 NFE2L1 Human reactive oxygen species decreases abundance EXP 6480464 NFE2L1 protein results in decreased abundance of Reactive Oxygen Species CTD PMID:33838154 NFE2L1 Human resveratrol increases expression EXP 6480464 resveratrol results in increased expression of NFE2L1 mRNA and resveratrol results in increased expression of NFE2L1 protein CTD PMID:25130429 and PMID:28960787 NFE2L1 Human rotenone multiple interactions EXP 6480464 NFE2L1 protein affects the reaction [Rotenone results in increased expression of PSMA2 mRNA] more ... CTD PMID:27345029 NFE2L1 Human sodium arsenite decreases expression EXP 6480464 sodium arsenite results in decreased expression of NFE2L1 mRNA CTD PMID:28595984 NFE2L1 Human sodium arsenite affects localization ISO Nfe2l1 (Mus musculus) 6480464 sodium arsenite affects the localization of NFE2L1 protein alternative form CTD PMID:28237703 NFE2L1 Human sodium arsenite increases response to substance ISO Nfe2l1 (Mus musculus) 6480464 NFE2L1 protein alternative form results in increased susceptibility to sodium arsenite CTD PMID:28237703 NFE2L1 Human sodium arsenite multiple interactions ISO Nfe2l1 (Mus musculus) 6480464 NFE2L1 protein alternative form inhibits the reaction [sodium arsenite results in increased cleavage of CASP3 protein] more ... CTD PMID:28237703 and PMID:28549828 NFE2L1 Human sodium arsenite decreases response to substance ISO Nfe2l1 (Mus musculus) 6480464 NFE2L1 protein alternative form results in decreased susceptibility to sodium arsenite CTD PMID:28549828 NFE2L1 Human sodium arsenite increases expression ISO Nfe2l1 (Mus musculus) 6480464 sodium arsenite results in increased expression of NFE2L1 protein alternative form CTD PMID:28549828 NFE2L1 Human sodium arsenite increases expression EXP 6480464 sodium arsenite results in increased expression of NFE2L1 mRNA and sodium arsenite results in increased expression of NFE2L1 protein CTD PMID:20805060 NFE2L1 Human sodium arsenite increases activity EXP 6480464 sodium arsenite results in increased activity of NFE2L1 protein CTD PMID:20805060 NFE2L1 Human sodium arsenite affects localization EXP 6480464 sodium arsenite affects the localization of NFE2L1 protein CTD PMID:20805060 NFE2L1 Human sodium arsenite multiple interactions EXP 6480464 [NFE2L1 protein alternative form co-treated with [sodium arsenite results in increased abundance of Arsenic]] results in increased expression of NFE2L2 mRNA more ... CTD PMID:20805060 and PMID:32188015 NFE2L1 Human sulindac increases expression EXP 6480464 Sulindac results in increased expression of NFE2L1 mRNA CTD PMID:11906190 NFE2L1 Human sulindac increases expression ISO Nfe2l1 (Rattus norvegicus) 6480464 Sulindac results in increased expression of NFE2L1 mRNA CTD PMID:24136188 NFE2L1 Human testosterone multiple interactions ISO Nfe2l1 (Rattus norvegicus) 6480464 Testosterone inhibits the reaction [Dexamethasone results in increased expression of NFE2L1 mRNA] CTD PMID:20032058 NFE2L1 Human trichloroethene increases expression ISO Nfe2l1 (Rattus norvegicus) 6480464 Trichloroethylene results in increased expression of NFE2L1 mRNA CTD PMID:33387578 NFE2L1 Human triphenyl phosphate increases expression ISO Nfe2l1 (Rattus norvegicus) 6480464 triphenyl phosphate results in increased expression of NFE2L1 mRNA CTD PMID:30589522 NFE2L1 Human triptonide affects expression ISO Nfe2l1 (Mus musculus) 6480464 triptonide affects the expression of NFE2L1 mRNA CTD PMID:33045310 NFE2L1 Human triticonazole decreases expression ISO Nfe2l1 (Rattus norvegicus) 6480464 triticonazole results in decreased expression of NFE2L1 mRNA CTD PMID:36084822 NFE2L1 Human tungsten decreases expression ISO Nfe2l1 (Mus musculus) 6480464 Tungsten results in decreased expression of NFE2L1 mRNA CTD PMID:30912803 NFE2L1 Human tunicamycin multiple interactions EXP 6480464 Tunicamycin affects the reaction [sodium arsenite affects the localization of NFE2L1 protein] CTD PMID:20805060 NFE2L1 Human urethane increases expression EXP 6480464 Urethane results in increased expression of NFE2L1 mRNA CTD PMID:28818685 NFE2L1 Human valproic acid affects expression ISO Nfe2l1 (Mus musculus) 6480464 Valproic Acid affects the expression of NFE2L1 mRNA CTD PMID:17963808 NFE2L1 Human valproic acid affects expression EXP 6480464 Valproic Acid affects the expression of NFE2L1 mRNA CTD PMID:25979313 NFE2L1 Human vinclozolin decreases expression ISO Nfe2l1 (Rattus norvegicus) 6480464 vinclozolin results in decreased expression of NFE2L1 mRNA CTD PMID:23034163 NFE2L1 Human vincristine increases expression EXP 6480464 Vincristine results in increased expression of NFE2L1 mRNA CTD PMID:23649840 NFE2L1 Human vitamin E increases expression EXP 6480464 Vitamin E results in increased expression of NFE2L1 mRNA CTD PMID:19244175
